Ian Hector Frazer, an immunologist born in Glasgow in 1953, developed the technology that enabled the cervical cancer vaccine. By synthesizing virus-like particles in vitro at the University of Queensland, he created a method to mimic the structure of the human papillomavirus, a breakthrough that fundamentally altered the clinical approach to preventing this specific cancer.
Academic Foundation
Educated at George Watson's College, Robert Gordon's College, and the University of Edinburgh, Frazer initially explored physics before shifting his focus to medicine. He earned his science and medical degrees between 1974 and 1977. His early career included residency positions at the Edinburgh Eastern General Hospital, the Edinburgh Royal Infirmary, and the Roodlands General Hospital in Haddington.
Twenty questions, eight minutes on the clock, and a percentile measured against everyone who has taken it. No sign-up.
Take the IQ test →Transition to Viral Immunology
In 1980, he moved to Melbourne after being recruited by the Walter and Eliza Hall Institute of Medical Research to study viral immunology. During his tenure there, he identified links between viral infections and immunodeficiency. Upon relocating to the University of Queensland in 1985 as a senior lecturer, he established research laboratories to investigate the relationship between human papillomavirus and precancerous cellular changes.
The Virus-Like Particle Innovation
Collaborating with virologist Jian Zhou during a 1989 sabbatical, Frazer sought a solution to the difficulty of culturing the papillomavirus. By 1991, their team successfully synthesized protein structures that mimicked the virus shell. This development led to a provisional patent in June 1991. The technology was later licensed for the production of vaccines designed to protect against strains responsible for 70 percent of cervical cancers.
Professional Recognition and Leadership
Frazer served as the founding CEO and Director of Research of the Translational Research Institute. His work has been recognized globally, including the 2008 Prime Minister's Prize for Science, the 2006 Florey Medal, and the 2008 Balzan Prize. He was elected a Fellow of the Australian Academy of Science in 2004 and a Fellow of the Royal Society in 2011.
Fast facts
- Born: 1953, Glasgow
- Citizenship: United Kingdom; Australia
- Education: University of Edinburgh
- Primary Affiliation: University of Queensland
- 2006 Australian of the Year
- 2008 Prime Minister's Prize for Science recipient
- 2011 Fellow of the Royal Society
Questions readers ask
What is Ian Frazer's primary medical contribution?
He developed the foundational technology for the human papillomavirus vaccine using virus-like particles.
Where did Frazer conduct his major research?
The majority of his seminal work on the papillomavirus was conducted at the University of Queensland.
Achievements
- Fellow of the Royal Society — 2011
- Balzan Prize — 2008
- Florey Medal — 2006
- Novartis Prize for Clinical Immunology — 2007
- Held posts at University of Queensland
